Literature DB >> 8787971

An oliogenic disease displaying weak marker associations: a summary of contributions to problem 1 of GAW9.

S E Hodge1.   

Abstract

Problem 1 consisted of artificial data simulated from an oligogenic (four-locus) disease model. The data set contained 200 nuclear families with at least one affected child and 100 control families with no affected members. Two of the disease loci were intended to be detectable via association analysis but not necessarily via linkage analysis, and the other two were virtually undetectable in this data set. Participants used association analysis, linkage analysis, and segregation analysis to analyze these data. Their findings are summarized, and analysis strategies are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8787971     DOI: 10.1002/gepi.1370120604

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  5 in total

1.  Using exact P values to compare the power between the reconstruction-combined transmission/disequilibrium test and the sib transmission/disequilibrium test.

Authors:  M Knapp
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

2.  Using all alleles in the multiallelic versions of the SDT and combined SDT/TDT.

Authors:  Wendy Czika; Jack J Berry
Journal:  Am J Hum Genet       Date:  2002-11       Impact factor: 11.025

3.  The transmission/disequilibrium test and parental-genotype reconstruction: the reconstruction-combined transmission/ disequilibrium test.

Authors:  M Knapp
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

4.  A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test.

Authors:  R S Spielman; W J Ewens
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

5.  Power studies for the transmission/disequilibrium tests with multiple alleles.

Authors:  N L Kaplan; E R Martin; B S Weir
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.